Export

Shire Human Genetic Therapies AB

Financial information

The information source is the annual report of the company with business id 556591-1764

* Closing information (×1000) SEK

Fiscal year 202303 202203 202103
Number of months: 12 12
Turnover: 0 Revenue Down 3,914 Revenue Down 68,080
Financial expenses: 0 0 Revenue Down 112
Earnings before taxes: 822 Revenue Up 95 Revenue Down 1,666
Total assets: 25,546 Revenue Up 24,730 Revenue Up 24,654
Current assets: 25,546 Revenue Up 24,728 Revenue Up 24,636
Current liabilities: 174 Revenue Up 10 Revenue Up 8
Equity capital: 25,372 Revenue Up 24,720 Revenue Up 24,646
Share capital: 1,000 1,000 1,000
Number of employees: 0 0 0

Financial ratios

Solvency: 99.3% Revenue Down 100.0% 100.0%
Turnover per employee: NaN Infinity Infinity
Profitability: Infinity% Revenue Up 2.4% 2.4%
Return on equity (ROE): 3.2% Revenue Up 0.4% Revenue Down 6.8%
Current ratio: 14.681.6% Revenue Down 247.280.0% Revenue Down 307.950.0%
Return on assets (ROA): 3.2% Revenue Up 0.4% Revenue Down 7.2%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202303
Number of months: 12
Turnover: 0
Financial expenses: 0
Earnings before taxes: 822
Total assets: 25,546
Current assets: 25,546
Current liabilities: 174
Equity capital: 25,372
Share capital: 1,000
Number of employees: 0

Financial ratios

Solvency: 99.3%
Turnover per employee: NaN
Profitability: Infinity%
Return on equity (ROE): 3.2%
Current ratio: 14.681.6%
Return on assets (ROA): 3.2%